Employer record · Miami, FL · FY2020–FY2026

Noven Pharmaceuticals, Inc.

    Certified LCAs
    3
    FY2024–FY2026
    USCIS approvals
    2
    0 new employment
    Denial rate
    33.3%
    FY2024–FY2026
    Median wage offered
    $100k
    certified LCAs

    Jobs not indexed yet

    Does Noven Pharmaceuticals, Inc. sponsor H-1B visas?

    Yes — by its record, Noven Pharmaceuticals, Inc. is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 2 USCIS H-1B petition approvals (0 for new employment). Its latest certified LCA in our data was decided Sep 17, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep) — 11 since FY2020; the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Noven Pharmaceuticals, Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2021100%
    FY2143100%
    FY220150%
    FY2321100%
    FY2411100%
    FY2511100%
    FY26100%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Chemical Engineers 17-20412$89k
    Natural Sciences Managers 11-91211$186k

    Most-filed job titles

    1. Process Engineer2$89k
    2. Associate Director Program Management1$186k

    LCAs per title and median wage offered.

    Where the jobs were

    1. Florida2 LCAs
    2. New Jersey1 LCAs

    We haven't indexed Noven Pharmaceuticals' jobs yet

    We read jobs straight from employers' own career sites and haven't added Noven Pharmaceuticals' yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • NOVEN PHARMACEUTICALS INC (USCIS)
    • Noven Pharmaceuticals, Inc. (LCA)
    • NOVEN PHARMACEUTICALS, INC. (USCIS)

    Noven Pharmaceuticals, Inc. H-1B: questions people ask

    Does Noven Pharmaceuticals, Inc. sponsor H-1B visas?

    Yes — by its record, Noven Pharmaceuticals, Inc. is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 2 USCIS H-1B petition approvals (0 for new employment). Its latest certified LCA in our data was decided Sep 17, 2026. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Noven Pharmaceuticals, Inc. still sponsoring H-1B in 2026?

    Noven Pharmaceuticals, Inc. had 1 certified LCAs in FY2026 (Oct 2025–Sep 2026), about the same as the 1 in FY2025. The latest one in our data was decided Sep 17, 2026. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Noven Pharmaceuticals, Inc. get approved?

    USCIS recorded 2 approvals (0 for new employment, the rest continuing employment such as extensions and transfers) and 1 denials for Noven Pharmaceuticals, Inc. in FY2024–FY2026 — a denial rate of 33.3%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Noven Pharmaceuticals, Inc.?

    The median wage offered on Noven Pharmaceuticals, Inc.'s certified LCAs in FY2024–FY2026 was $100k a year. By job title: Process Engineer $89k (2 LCAs) and Associate Director Program Management $186k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Noven Pharmaceuticals, Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Chemical Engineers (2) and Natural Sciences Managers (1).

    Where are Noven Pharmaceuticals, Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): Florida (2) and New Jersey (1).

    Is Noven Pharmaceuticals, Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Noven Pharmaceuticals, Inc. have open jobs?

    We read jobs straight from employers' own career sites and haven't added Noven Pharmaceuticals' yet.